| |
H1N1
(n=5) |
Other diagnostics (n=124) |
P |
| n (%) |
n (%) |
| Clinical characteristics |
| Age (years) |
60,8±10,4 |
72,2±10 |
0,015 |
| height (cm) |
170±4,1 |
163±6,5 |
0,058 |
| Obesity |
1 (20) |
4 (3,2) |
0,238 |
| Non smoker (years) |
3±3 |
8,97±10,2 |
0,06 |
| Hospitalization last year (n) |
2 (40) |
16 (12,9) |
0,143 |
Grade obstruction
(FVC/FEV1 post BD) |
43±3,5 |
49,6±13,5 |
0,019 |
| Episode clinical |
| Peak temperature (ºC) |
38,4±0,67 |
37,1±1 |
0,027 |
| Congestion |
2 (40) |
10 (8) |
0,068 |
| Headache |
2 (40) |
3 (2,4) |
0,020 |
| Laboratory data |
| Total lymphocytes (mm3) |
912±379 |
1498±2198 |
0,036 |
| Hematocrit (%) |
46,5±2,6 |
42,3±4,7 |
0,02 |
| Treatment |
| Inhaled corticoids |
3 (60) |
27 (21,7) |
0,084 |
| Antipyretics |
5 (100) |
53 (42,7) |
0,017 |
| Mechanical ventilation |
2 (40) |
7 (5,6) |
0,039 |
| Clinical evolution |
Early evaluation
Failure
Improvement |
1 (20)
3 (60) |
1 (0,8)
113 (91,1) |
0,030 |
Clinical failure
No
Respiratory failure |
2 (40)
3 (60) |
115 (92,7)
6 (4,8) |
0,011 |
| ICU admission |
2 (40) |
7 (5,6) |
0,039 |
| Change of antibiotics |
| No change |
1 (20) |
78 (62,9) |
0,014 |
| Resistance |
0 (0) |
10 (8) |
| Empiric |
3 (60) |
35 (28,2) |
|
